Target- |
MechanismCytotoxic T lymphocytes stimulants |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with McGill-Queen's University Press
0 Patents (Medical) associated with McGill-Queen's University Press
100 Deals associated with McGill-Queen's University Press
100 Translational Medicine associated with McGill-Queen's University Press